How do I taper off estradiol (estrogen) patch and oral progesterone (progestin) hormone replacement therapy (HRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tapering off hormone replacement therapy (HRT) should always be done under medical supervision, with a gradual approach to minimize withdrawal symptoms and risks, as recommended by the most recent guidelines 1. The general approach involves gradually reducing the estradiol patch strength over 3-6 months while maintaining your progesterone dose until the estrogen is completely discontinued.

  • For example, if you're using a 0.1mg estradiol patch, your doctor might have you switch to 0.075mg or 0.05mg for 4-8 weeks, then to 0.025mg for another 4-8 weeks before stopping completely.
  • Once you've stopped estradiol, you can then discontinue the oral progesterone. This gradual approach helps minimize withdrawal symptoms like hot flashes, mood changes, and sleep disturbances, as well as reducing the risk of osteoporosis and other chronic conditions associated with abrupt hormone withdrawal 1. The tapering schedule should be personalized based on your current dosage, how long you've been on HRT, and your medical history, with regular follow-up appointments with your healthcare provider to monitor your symptoms and overall health 1. Some women experience return of menopausal symptoms during tapering, which may require adjustments to the schedule, and it's essential to work closely with your healthcare provider to manage these symptoms and ensure a safe and effective tapering process. Key considerations in tapering HRT include:
  • Using the lowest effective dose for the shortest possible time, as recommended by the Annals of Internal Medicine 1.
  • Avoiding routine use of HRT for primary prevention of chronic conditions, unless the benefits outweigh the risks for the individual patient 1.
  • Monitoring for potential side effects and adjusting the tapering schedule as needed to minimize risks and ensure the best possible outcomes.

From the Research

Weaning Off Estradiol Patch and Oral Progestin

To taper off estradiol (estrogen) patch and oral progesterone (progestin) hormone replacement therapy (HRT), consider the following steps:

  • Gradually reduce the dosage of estradiol patch and oral progesterone over a period of time to minimize withdrawal symptoms and potential side effects 2, 3.
  • One approach is to decrease the dose of estradiol patch by a small amount (e.g., 25% reduction) every 1-2 weeks, while maintaining the same dose of oral progesterone 4.
  • Alternatively, the dose of oral progesterone can be reduced first, followed by a gradual decrease in the estradiol patch dose 5.
  • It is essential to monitor for any signs of withdrawal bleeding, endometrial stimulation, or other side effects during the tapering process 6, 2.

Considerations for Tapering HRT

When tapering off HRT, keep in mind:

  • The risk of endometrial adenocarcinoma and the importance of evaluating spontaneous postmenopausal bleeding 6.
  • The potential benefits of continuous combined regimens, which may minimize bleeding and side effects 2.
  • The effects of progestins on the cardiovascular system, which may attenuate the benefits of estrogen replacement therapy 5.
  • The importance of individualized treatment and monitoring to minimize risks and side effects 2, 3.

Monitoring and Follow-Up

Regular monitoring and follow-up are crucial during the tapering process to:

  • Assess endometrial thickness and stability using transvaginal ultrasound and endometrial biopsy, if necessary 4, 3.
  • Evaluate symptom relief, bleeding, and side effects 3.
  • Adjust the tapering schedule as needed to minimize withdrawal symptoms and potential side effects 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

HRT dosing regimens: continuous versus cyclic-pros and cons.

International journal of fertility and women's medicine, 2001

Research

A novel regimen of combination transdermal estrogen and intermittent vaginally administered progesterone for relief of menopausal symptoms.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010

Research

Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.

Climacteric : the journal of the International Menopause Society, 2012

Research

Disturbances of endometrial bleeding with hormone replacement therapy.

Human reproduction (Oxford, England), 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.